Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
多中心、随机、双盲、安慰剂平行对照评价苏合颗粒治疗慢性萎缩性胃炎(脾虚瘀滞证)的有效性及安全性的Ⅱ期临床试验
[Translation] A multicenter, randomized, double-blind, placebo-controlled phase II clinical trial evaluating the efficacy and safety of Suhe granules in the treatment of chronic atrophic gastritis (spleen deficiency and blood stasis syndrome).
主要目的:
评价苏合颗粒治疗慢性萎缩性胃炎的有效性。
次要目的:
评价苏合颗粒治疗慢性萎缩性胃炎的安全性。
探索苏合颗粒治疗慢性萎缩性胃炎的合理剂量。
探索苏合颗粒治疗慢性萎缩性胃炎的PD特征。
[Translation] Primary Objective: To evaluate the efficacy of Suhe granules in the treatment of chronic atrophic gastritis.
Secondary Objective: To evaluate the safety of Suhe granules in the treatment of chronic atrophic gastritis.
To explore the optimal dosage of Suhe granules for the treatment of chronic atrophic gastritis.
To explore the disease progression (PD) characteristics of Suhe granules in the treatment of chronic atrophic gastritis.
100 Clinical Results associated with Chongqing Juqi Nuomei Pharmaceutical Co., Ltd
0 Patents (Medical) associated with Chongqing Juqi Nuomei Pharmaceutical Co., Ltd
100 Deals associated with Chongqing Juqi Nuomei Pharmaceutical Co., Ltd
100 Translational Medicine associated with Chongqing Juqi Nuomei Pharmaceutical Co., Ltd